Search Results

There are 14537 results for: content related to: Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection

  1. You have free access to this content
    The impact of hepatitis C virus outside the liver: Evidence from Asia

    Liver International

    Volume 37, Issue 2, February 2017, Pages: 159–172, Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young-Suk Lim, Ming-Lung Yu, Norifumi Kawada, Yock Young Dan, Craig Brooks-Rooney, Francesco Negro and Mario U. Mondelli

    Version of Record online : 10 NOV 2016, DOI: 10.1111/liv.13272

  2. You have free access to this content
    Optimal therapy in genotype 4 chronic hepatitis C: finally cured?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 27–34, Wael Abdel-Razek and Imam Waked

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12724

  3. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 120–129, Raffaele Bruno, Giuseppe Cariti, Paola Nasta, Amedeo Capetti, Veronica Ravasio, Massimo Galli, Enzo Raise, Giulio Palmieri, Claudio Iannacone and Massimo Puoti

    Version of Record online : 11 AUG 2014, DOI: 10.1111/liv.12641

  4. You have free access to this content
    Treatment of hepatitis C virus genotype 3-infection

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 18–23, Stanislas Pol, Anaïs Vallet-Pichard and Marion Corouge

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12405

  5. You have free access to this content
    A pill for HCV – myth or foreseeable future?

    Liver International

    Volume 34, Issue 1, January 2014, Pages: 6–11, Jerzy Jaroszewicz, Robert Flisiak and Geoffrey Dusheiko

    Version of Record online : 2 SEP 2013, DOI: 10.1111/liv.12294

  6. Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

    Liver International

    Volume 37, Issue 4, April 2017, Pages: 514–528, Velia C. Di Maio, Valeria Cento, Ilaria Lenci, Marianna Aragri, Piera Rossi, Silvia Barbaliscia, Michela Melis, Gabriella Verucchi, Carlo F. Magni, Elisabetta Teti, Ada Bertoli, FrancescoPaolo Antonucci, Maria C. Bellocchi, Valeria Micheli, Chiara Masetti, Simona Landonio, Simona Francioso, Francesco Santopaolo, Adriano M. Pellicelli, Vincenza Calvaruso, Laura Gianserra, Massimo Siciliano, Dante Romagnoli, Raffaele Cozzolongo, Antonio Grieco, Jacopo Vecchiet, Filomena Morisco, Manuela Merli, Giuseppina Brancaccio, Antonio Di Biagio, Elisabetta Loggi, Claudio M. Mastroianni, Valeria Pace Palitti, Pierluigi Tarquini, Massimo Puoti, Gloria Taliani, Loredana Sarmati, Antonino Picciotto, Vincenzo Vullo, Nicola Caporaso, Maurizio Paoloni, Caterina Pasquazzi, Giuliano Rizzardini, Giustino Parruti, Antonio Craxì, Sergio Babudieri, Massimo Andreoni, Mario Angelico, Carlo F. Perno, Francesca Ceccherini-Silberstein and for the HCV Italian Resistance Network Study Group

    Version of Record online : 20 JAN 2017, DOI: 10.1111/liv.13327

  7. You have free access to this content
    Hepatitis C: efficacy and safety in real life

    Liver International

    Volume 37, Issue S1, January 2017, Pages: 26–32, Robert Flisiak, Joanna Pogorzelska and Marta Flisiak-Jackiewicz

    Version of Record online : 3 JAN 2017, DOI: 10.1111/liv.13293

  8. You have free access to this content
    How to optimize HCV therapy in genotype 1 patients with cirrhosis

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 46–55, Marc Bourlière, Astrid Wendt, Hélène Fontaine, Christophe Hézode, Stanislas Pol and Jean Pierre Bronowicki

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12067

  9. You have free access to this content
    HCV F1/F2 patients: treat now or continue to wait

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 79–84, Mitchell L. Shiffman and Yves Benhamou

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12408

  10. You have full text access to this OnlineOpen article
    HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape

    Liver International

    Volume 36, Issue 4, April 2016, Pages: 488–502, Nancy Reau, Michael W. Fried, David R. Nelson, Robert S. Brown Jr, Gregory T. Everson, Stuart C. Gordon, Ira M. Jacobson, Joseph K. Lim, Paul J. Pockros, K. Rajender Reddy and Kenneth E. Sherman

    Version of Record online : 22 NOV 2015, DOI: 10.1111/liv.12993

  11. You have free access to this content
    Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 105–110, Mitchell L. Shiffman and Yves Benhamou

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12066

  12. You have free access to this content
    Pegylated interferon based therapy with second-wave direct-acting antivirals in genotype 1 chronic hepatitis C

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 11–17, Nicole M. Welch and Donald M. Jensen

    Version of Record online : 22 DEC 2014, DOI: 10.1111/liv.12715

  13. Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1522–1531, Yan Xu, Wenqian Qi, Xu Wang, Ping Zhao, Yonggui Zhang, Qian Zhang, Shaoyou Qin and Jiangbin Wang

    Version of Record online : 12 DEC 2013, DOI: 10.1111/liv.12417

  14. You have free access to this content
    HCV direct-acting antiviral agents: the best interferon-free combinations

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 69–78, Raymond Schinazi, Philippe Halfon, Patrick Marcellin and Tarik Asselah

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12423

  15. Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 79–89, Edward J. Gane, Paul J. Pockros, Stefan Zeuzem, Patrick Marcellin, Anna Shikhman, Coen Bernaards, Julian Zhou, Ellen S. Yetzer, Rosa Ballester, Cindy Dwyer, Xiao Tong, Isabel Nájera, Anne Bertasso, Janet Hammond, Amy Kindrick, Peter N. Morcos, Patrick Smith, Saray Stancic and Nancy S. Shulman

    Version of Record online : 18 JUN 2014, DOI: 10.1111/liv.12588

  16. You have free access to this content
    Optimal treatment with boceprevir for chronic HCV infection

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 14–22, Benjamin Maasoumy and Michael P. Manns

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12070

  17. High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity

    Liver International

    Volume 36, Issue 3, March 2016, Pages: 344–352, Susanne Johansson, Willem Talloen, Marianne Tuefferd, Jama Darling, Gregory Fanning, Michael W. Fried and Jeroen Aerssens

    Version of Record online : 6 SEP 2015, DOI: 10.1111/liv.12932

  18. You have free access to this content
    Best strategies for global HCV eradication

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 68–79, Liesl M. Hagan and Raymond F. Schinazi

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12063

  19. You have free access to this content
    How to optimize HCV therapy in genotype 2 patients

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 35–40, Eleonora Grassi and Alessio Aghemo

    Version of Record online : 3 JAN 2013, DOI: 10.1111/liv.12056

  20. You have free access to this content
    Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment

    Liver International

    Volume 37, Issue S1, January 2017, Pages: 19–25, Marcus M. Mücke, Victoria T. Mücke, Christian M. Lange and Stefan Zeuzem

    Version of Record online : 3 JAN 2017, DOI: 10.1111/liv.13279